Maintenance rituximab after autologous stem cell transplant for high-risk B-cell lymphoma induces prolonged and severe hypogammaglobulinemia.
Lim
S H
SH
Zhang
Y
Y
Wang
Z
Z
Esler
W V
WV
Beggs
D
D
Pruitt
B
B
Hancock
P
P
Townsend
M
M
D000361:Agammaglobulinemia / Q000139:chemically induced*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007075:Immunoglobulin M / Q000097:blood; D016393:Lymphoma, B-Cell / Q000150:complications / Q000628:therapy*; D008297:Male; D000069283:Rituximab; D014182:Transplantation, Autologous
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D000069283:Rituximab